Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1405896

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405896

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing), By End-use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 104 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

  • HbA1c tests segment held largest revenue share in 2023 and is attributable to the increasing prevalence of diabetic population
  • HGB/HCT tests segment is expected to show fastest growth rate over the forecast period owing to the growing prevalence of blood-related disorders
  • Central laboratories segment dominated the market in 2023 attributable to the high market penetration and procedure volumes
  • North America held the largest market share in 2023 which can be attributed to the growing regulatory support and increase in investments in clinical laboratory tests
Show more
Product Code: 978-1-68038-361-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Growing prevalence of target disease
      • 3.2.1.3. Introduction of innovative solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. COVID-19 pandemic
  • 3.3. Clinical Laboratory Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Laboratory Tests Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Complete Blood Count
      • 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. HGB/HCT Testing
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3. Basic Metabolic Panel Testing
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.4. BUN Creatinine Testing
      • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.5. Electrolytes Testing
      • 4.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.6. HbA1c Testing
    • 4.4.7. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.8. Comprehensive Metabolic Panel Testing
      • 4.4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.9. Liver Panel Testing
      • 4.4.9.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.2. Hepatitis
      • 4.4.9.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.3. Bile Duct Obstruction
      • 4.4.9.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.4. Liver Cirrhosis
      • 4.4.9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.5. Liver Cancer
      • 4.4.9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.6. Bone Disease
      • 4.4.9.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.7. Autoimmune Disorders
      • 4.4.9.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.8. Others
      • 4.4.9.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.10. Renal Panel Testing
      • 4.4.10.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.11. Lipid Panel Testing
      • 4.4.11.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.12. Cardiovascular Panel Testing
      • 4.4.12.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Laboratory Tests Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Central Laboratories
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. Primary Clinics
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CINVEN
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QUEST DIAGNOSTICS INCORPORATED
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. OPKO HEALTH, INC.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. F. Laboratory Corporation of America Holdings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. UNILABS
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Synnovis Group LLP
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. SONIC HEALTHCARE
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
Show more
Product Code: 978-1-68038-361-4

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 U.S. clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 10 Europe clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Europe clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Germany clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Norway clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Norway clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 China clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 South Korea clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 38 South Korea clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Australia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Australia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Thailand clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 42 Thailand clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America clinical laboratory tests market, by application, 2018 - 2030 (USD Billion)
  • Table 46 Brazil clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 MEA clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 53 MEA clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 54 MEA clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 South Africa clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 UAE clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical laboratory tests market: market outlook
  • Fig. 14 Clinical laboratory tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical laboratory tests market driver impact
  • Fig. 20 Clinical laboratory tests market restraint impact
  • Fig. 21 Clinical laboratory tests market strategic initiatives analysis
  • Fig. 22 Clinical laboratory tests market: Type movement analysis
  • Fig. 23 Clinical laboratory tests market: Type outlook and key takeaways
  • Fig. 24 CBC market estimates and forecast, 2018 - 2030
  • Fig. 25 HGB/HCT test market estimates and forecast, 2018 - 2030
  • Fig. 26 Basic metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 27 BUN creatinine test market estimates and forecast, 2018 - 2030
  • Fig. 28 Electrolyte tests market estimates and forecast, 2018 - 2030
  • Fig. 29 HbA1c tests market estimates and forecast, 2018 - 2030
  • Fig. 30 Comprehensive metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 31 Liver panel test market estimates and forecast, 2018 - 2030
  • Fig. 32 Hepatitis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 35 Liver cancer liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 36 Bone disease liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 38 Others liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 39 Renal panel test market estimates and forecast, 2018 - 2030
  • Fig. 40 Lipid panel tests market estimates and forecast, 2018 - 2030
  • Fig. 41 Cardiovascular panel test market estimates and forecast, 2018 - 2030
  • Fig. 42 Clinical laboratory tests market: End-use movement Analysis
  • Fig. 43 Clinical laboratory tests market: End-use outlook and key takeaways
  • Fig. 44 Central Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 45 Primary Clinics market estimates and forecasts,2018 - 2030
  • Fig. 46 Global clinical laboratory tests market: Regional movement analysis
  • Fig. 47 Global clinical laboratory tests market: Regional outlook and key takeaways
  • Fig. 48 Global clinical laboratory tests market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Denmark
  • Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 82 Norway
  • Fig. 83 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 84 Asia Pacific
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 86 China
  • Fig. 87 China market estimates and forecasts, 2018 - 2030
  • Fig. 88 Japan
  • Fig. 89 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 90 India
  • Fig. 91 India market estimates and forecasts, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 94 South Korea
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 96 Australia
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Latin America
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 100 Brazil
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 102 Mexico
  • Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 116 Market share of key market players- Clinical laboratory tests market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!